Arterial stiffness in chronic renal failure and after renal transplantation

L Löcsey1, B Szlanka, B Borbás

  • 1Institute of Surgery, Medical and Health Science Center, University of Debrecen, Debrecen, Hungary.

Insights

Arterial stiffness markers like augmentation index (AIx) and pulse wave velocity (PWV) are elevated in renal transplant recipients, indicating increased cardiovascular risk. Arteriography effectively detects early atherosclerosis in these patients.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Vascular Biology

Background:

  • Arterial stiffness, a key cardiovascular risk factor, is associated with aging, hypertension, and cardiovascular disease.
  • Augmentation index (AIx) and pulse wave velocity (PWV) serve as early indicators of atherosclerotic vascular changes.

Purpose of the Study:

  • To evaluate arterial stiffness using AIx and PWV in renal transplant recipients.
  • To assess cardiovascular risk factors and atherosclerotic changes in this population.
  • To determine the utility of arteriography in diagnosing and monitoring atherosclerosis post-transplantation.

Main Methods:

  • Arteriography was employed to measure blood pressure, pulse pressure (PP), AIx, and PWV in 146 renal transplant recipients (82 male, 64 female).
  • Cardiovascular risk was further assessed via echocardiography and carotid artery ultrasonography.
  • Biomarkers including serum creatinine, cystatin C, homocysteine, and lipid profiles were analyzed.

Main Results:

  • Elevated AIx (> or =10%) was observed in 20% of men and 37% of women; elevated PWV (>10 m/s) in 43% of men and 34% of women.
  • PWV showed significant correlations with age (r=0.52) and left ventricular wall thickness (r=0.46).
  • A strong association was found between carotid artery stenosis and elevated PWV and AIx80, with all patients exceeding 10 m/s PWV exhibiting carotid stenosis.

Conclusions:

  • Arteriography is a valuable, noninvasive method for the early detection and follow-up of atherosclerosis in renal transplant recipients.
  • Renal transplant recipients exhibit significant arterial stiffness, highlighting their increased cardiovascular risk.
  • Post-transplantation changes, including increased BMI and fat mass, may contribute to arterial stiffness.

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...